Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Crinetics Pharmaceuticals Inc shares valued at $1,277,625 were purchased by MARC WILSON on Sep 26 ’24. At $51.10 per share, MARC WILSON acquired 25,000 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Betz Stephen F. sold 1,035 shares, netting a total of over 53,302 in proceeds. Following the sale of shares at $51.50 each, the insider now holds 68,576 shares.
Before that, Betz Stephen F. had added 1,035 shares to its account. In a trade valued at $53,301, the Officer bought Crinetics Pharmaceuticals Inc shares for $51.50 each.
As published in their initiating research note from Citigroup on March 06, 2024, Crinetics Pharmaceuticals Inc [CRNX] has been a Buy and the price target has been revised to $68. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid January. As of December 21, 2023, Jefferies has initiated its “Hold” rating for CRNX.
Analyzing CRNX Stock Performance
During the last five days, there has been a drop of approximately -6.12%. Over the course of the year, Crinetics Pharmaceuticals Inc shares have jumped approximately 42.16%. Shares of the company reached a 52-week high of $55.78 on 07/23/24 and a 52-week low of $33.67 on 01/05/24. A 50-day SMA is recorded $52.11, while a 200-day SMA reached $44.93. Nevertheless, trading volume fell to 0.68 million shares from 0.7 million shares the previous day.
Support And Resistance Levels for Crinetics Pharmaceuticals Inc (CRNX)
According to the 24-hour chart, there is a support level at 49.97, which, if violated, would cause prices to drop to 49.36. In the upper region, resistance lies at 51.50. The next price resistance is at 52.42. RSI (Relative Strength Index) is 45.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.60, which suggests the price will decrease in the coming days. Percent R is at 75.89%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
